Medicine
Recognizing and Treating Immune Checkpoint Inhibitor-Induced Myocarditis
Quick fact
Immune checkpoint inhibitor-induced myocarditis, though rare (around 1% of treated patients), often manifests within the first two months of therapy and carries a mortality rate of up to 50% when fulminant.
Why this is interesting
When cancer immunotherapy turns the immune system against a tumor, what happens when that same army mistakenly attacks the heart?